Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Institution	Shares	Value	Change
BlackRock, Inc.	4,841,597	$821M	DECREASED
VANGUARD PORTFOLIO MANAGEMENT LLC	2,193,417	$372M	NEW
VANGUARD CAPITAL MANAGEMENT LLC	1,432,088	$243M	NEW
WASATCH ADVISORS LP	1,423,424	$241M	INCREASED
Conestoga Capital Advisors, LLC	1,251,189	$212M	INCREASED

Balchem Corporation (BCPC) Ownership & Trading Activity

Top Institutional Holders